Find FineTest ELISA Kits Adaptable to Novel Coronavirus Variants

Get Shareable Link

Abstract:      People are scared of novel coronavirus variants reported by many news and worry about . There are 23 mutations on the gene sequence of variable viruses. According to UK data, the incidence rate of novel coronavirus variants increases to 70%. The variants have a stronger impact on young people and drug resistance on vaccines. There are a variety of novel coronavirus variants. Now, two of them have been found.
Keywords:   2019-nCoV, CVOID-19, Novel Coronavirus Variants, S Protein, N Protein, IgG ELISA Kit for COVID-19, FineTest ELISA Kit

1. Three Most Common Concerned Questions for 2019-nCoV

  • Are the novel coronavirus variants really more severe as reported?
  • Are vaccines effective for novel coronavirus variants?
  • Do 2019-nCoV ELISA kits fit for novel coronavirus variants?

2. Explanations of Questions for 2019-nCoV

With some data and professional knowledge released by authorities, explanations are outlined below for your reference.

2.1. Higher Spread Speed Doesn't Mean the Stronger Pathogenicity

There is a mutation on S protein indeed. Currently, about 4,000 mutations are tested by UK. However, the mutation has no direct relation with pathogenicity or whether the transmission is stronger. 2019-nCoV is the RNA virus. The mutation randomly happens during virus replication. The mutation more beneficial to reproduction and transmission will be screened and retained. It's not surprised for virus variants to evolve towards the beneficial mutation. Will the virus evolve towards stronger pathogenicity? The strong pathogenicity will accelerate the death of the host, which doesn't help the survival and reproduction. Hence, some viruses in the nature will evolve towards weaker pathogenicity during enhancing their transmission ability.

2.2. No Evidences for the Impact of Novel Coronavirus Variants on Vaccines

Vaccines can produce antibodies against many S protein areas. The possibility that single virus mutation can decrease the efficiency of vaccines is low. There are many proteins in 2019-nCoV. Currently, only mutations on S protein are tested. However, It still remains to be seen whether these mutations can influence vaccines. So far, Prof. Nanshan Zhong said: "further evidences for whether the mutation will influence the efficiency of vaccines are unavailable".

2.3. Select N Protein ELISA Kit

In fact, from the information mentioned before, we probably know variants of 2019-nCoV are mainly in S protein. Evidences on whether novel coronavirus variants in S protein change the antigenicity and match with S protein antigen-antibody before the variation are unavailable. Theoretically speaking, the single virus mutation has a low impact on the whole S protein antigen-antibody. If you are really worried, please select FineTest N protein ELISA kit to conduct your scientific research. FineTest ELISA kit has high performance with a reasonable price.

IgG ELISA Kit

Figure 1. Human anti-SARS-CoV2(N) IgG ELISA Kit.

3. FineTest 2019-nCoV Product Line

Currently, FineTest offers 7,000+ ELISA kits, including 2019-nCoV products and regular ELISA kits. Please feel free to contact us to order your ELISA products.